US Financial Advisors’s Integra LifeSciences IART Stock Holding History

US Financial Advisors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-64	Closed	-$2K	–	180
2016 Q1	$2K	Hold	64	–	–	﹤0.01%	320
2015 Q4	$2K	Hold	64	–	–	﹤0.01%	457
2015 Q3	$2K	Sell	64 -14	-18%	-$438	﹤0.01%	393
2015 Q2	$2K	Buy	+78	New	+$2.08K	﹤0.01%	370

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

US Financial Advisors's IART Position: Q2 2016 in Review

US Financial Advisors sold out of Integra LifeSciences (IART) in Q2 2016, closing a stake of 64 shares — an estimated $2K sold.

US Financial Advisors first reported a position in IART in Q2 2015 and held it in 4 quarters. The position peaked at $2K in Q1 2016. 210 funds tracked by Wall St. Rank hold IART as of Q2 2016.

US Financial Advisors reported no remaining Integra LifeSciences position as of Q2 2016 after selling out during the quarter.
US Financial Advisors sold 64 Integra LifeSciences shares in Q2 2016, an estimated $2K.
US Financial Advisors first reported a position in Integra LifeSciences in Q2 2015 and held it in 4 quarters.
US Financial Advisors's Integra LifeSciences position peaked at $2K in Q1 2016.
210 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2016.

Based on US Financial Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.